Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...

Inhalable nanovaccines offer needle-free, mucosal immunity against respiratory diseases like COVID-19, influenza, and TB. Explore delivery mechanisms, key technologies, and future breakthroughs.

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels about heart inflammation.

Overview of RNA Therapeutics MarketThe Global RNA Therapeutics Market is valued at USD 10.9 Billion in 2024 and is projected ...

Moderna said on Friday it has filed a marketing application for the review of its updated COVID-19 vaccine with the U.S. Food ...

HHS Secretary Robert F. Kennedy Jr. on Tuesday announced that the CDC will no longer recommend COVID-19 vaccines for healthy ...

Kennedy Jr. -- are restricting access to COVID shots that were a signature accomplishment of President Trump's first term and ...

As bird flu sweeps across US poultry and cattle farms, researchers are racing to find ways to contain the outbreaks before ...

The FDA has told vaccine manufacturers to expand the warning labels on their COVID-19 shots with more information about the ...

A new type of coronavirus vaccine administered nasally has proven effective when tested on animals, researchers at the ...